Home Pilots AION Labs launches CombinAble.AI to design antibodies for therapeutic development Pilots AION Labs launches CombinAble.AI to design antibodies for therapeutic development By - March 15, 2024 80 0 Facebook Twitter Pinterest WhatsApp The Israel-based company is the result of AION Labs’ fifth startup challenge. RELATED ARTICLESMORE FROM AUTHOR Pilots Former Ripple exec Greg Kidd buys Know Labs with Bitcoin Pilots RadNet acquires See-Mode Technologies for access, revenue growth Pilots FDA launches AI tool for its employees LEAVE A REPLY Cancel reply Please enter your comment! Please enter your name here You have entered an incorrect email address! Please enter your email address here Save my name, email, and website in this browser for the next time I comment. FOLLOW ME0FansLike0FollowersFollow0SubscribersSubscribe POPULAR ARTICLES Q&A: Better Health scores $14M to scale medical support and supply company Pilots - June 13, 2024 0 AI medical coding company CodaMetrix raises $55M and more digital health fundings Pilots - March 2, 2023 0 Q&A: Former VA Secretary Shulkin on digital health refining patient-first care Pilots - January 13, 2023 0 Qritive, Corista tie up for digital pathology integration Pilots - March 20, 2023 0 Flo Health reaches unicorn status after $200M raise Pilots - July 31, 2024 0 POPULAR CATEGORIESPilots2369Applications835Testing285Collaborations15GitHub3